𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cost-effectiveness analysis of irinotecan plus fluorouracil/folinic acid compared with fluorouracil/folinic acid alone as first-line treatment for advanced colorectal cancer

✍ Scribed by Warren Mark Hart; Carlos Rubio-Terrés; Linda Pronk; Svetlana Kobina; Eduardo Díaz Rubio

Book ID
110646319
Publisher
Springer Milan
Year
2003
Tongue
Spanish
Weight
188 KB
Volume
5
Category
Article
ISSN
1699-048X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized phase III Study of 5-fluorour
Randomized phase III Study of 5-fluorouracil plus high dose folinic acid versus 5-fluorouracil plus folinic acid plus methyl-lomustine for patients with advanced colorectal cancer
✍ Dennie V. Jones; Roger J. Winn; Barry W. Brown; Lawrence B. Levy; Reginald P. Pu 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB

Background. Metastatic colorectal cancer is generally incurable. The most active regimen available, 5-fluorouracil(5-FU) and folinic acid (Leucovorin), produces response rates of approximately 25% to 30%. Methyl-lomustine is a nitrosourea with modest activity against colorectal cancer. A randomized